Kyntra Bio

KYNBNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$29.430 M

$7.27 +4.15%

Close of 7 Aug 2026

Revenue

$6.44M

#3257 by revenue

Earnings

$183.5M

#1048 by earnings

Shares outstanding

4,048,112

Latest filing cover page

P/E ratio

0.2

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#374Mira PharmaceuticalsMIRA$31.1M
#375Lite StrategyLITS$30.9M
#376Kyntra BioKYNB$29.4M
#377Grace TherapeuticsGRCE$28.6M
#378Rockwell MedicalRMTI$28.2M

Where these numbers come from

Share counts and financials for Kyntra Bio are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.